Cargando…
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
INTRODUCTION: Prolactin-secreting adenoma (PRLoma) can present as large and invasive neoplasm, with increased markers of cellular proliferation. First-line approach is Dopamine Agonists (DAs) treatment; however, DA-resistance has been reported, especially in male patients. Estrogens induce lactotrop...
Autores principales: | Ceccato, Filippo, Lizzul, Laura, Voltan, Giacomo, Barbot, Mattia, Scaroni, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550050/ https://www.ncbi.nlm.nih.gov/pubmed/34173929 http://dx.doi.org/10.1007/s11102-021-01165-0 |
Ejemplares similares
-
Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis
por: Mondin, Alessandro, et al.
Publicado: (2022) -
Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas
por: Voltan, Giacomo, et al.
Publicado: (2023) -
The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas
por: Dalle Nogare, Mattia, et al.
Publicado: (2023) -
Thyrotropin-Secreting Pituitary Adenoma Successfully Treated With Cabergoline
por: Saand, Aisha R, et al.
Publicado: (2021) -
The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
por: Regazzo, Daniela, et al.
Publicado: (2022)